Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is ...

The Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ: ...

Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...

Airbus has completion of a first flight for German Aerospace Center's (DLR) modified Airbus A320 ATRA for the E-Scan radar ...

HC Wainwright issued their FY2024 EPS estimates for Atara Biotherapeutics in a research note issued to investors on Wednesday, January 22nd. HC Wainwright analyst R. Burns forecasts that the ...

Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...

Atara stock plunges 41% upon the FDA issuance of a CRL against its BLA for Ebvallo to treat EBV+ PTLD. The company is also facing a severe cash crunch.

Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at HC ...

Atara Biotherapeutics (ATRA) stock slips as company faces an FDA clinical hold after rejection of lead candidate Ebvallo.

Airbus announced that, on Jan. 21, 2025, the A320 ATRA (Advanced Technology Research Aircraft) flew for the first time from the German Aerospace Center (DLR) in Braunschweig, Germany, after the ...

Atara Biotherapeutics, Inc.’s ATRA share price has dipped by 40.50%, which has investors questioning if this is right time to ...